Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-03-22
2011-03-22
Goddard, Laura B (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S006120, C435S007230
Reexamination Certificate
active
07910315
ABSTRACT:
A variety of methods, compositions and kits are provided for the early detection, diagnosis and treatment of hemangiosarcoma in dogs and angiosarcomas in humans.
REFERENCES:
patent: 7354729 (2008-04-01), Rich
patent: 2002/0009759 (2002-01-01), Terstappen et al.
patent: WO 03/037172 (2003-05-01), None
patent: WO 03/095977 (2003-11-01), None
patent: WO 2005/043121 (2005-05-01), None
Arber et al. American Journal of Surgical Pathology. 1997. vol. 21, No. 7; p. 827-835 (IDS).
Tockman et al (Cancer Res., 1992, 52:2711s-2718s).
Kern et al (Cytometry Part B, Clinical Cytometry, 2003, 55B:29-36).
Escribano et al (Analyitical Cellular Pathology, 1998, 16:151-159).
Paietta et al (Cytometry Part B, Clinical Cytometry, 2004, 59B:1-9).
Arber et al., “Splenic vascular tumors: A histologic, immunophenotypic, and virologic study”,American Journal of Surgical Pathology, 21:827-835 (1997).
Breiteneder-Geleff et al., “Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries”,American Journal of Pathology, 154:385-394 (1999).
Brown et al., “Canine hemangiosarcoma: retrospective analysis of 104 cases”,J. Am. Vet. Med. Assoc., 186:56-58 (1985).
Budd G. T., “Management of angiosarcoma”,Curr. Oncol. Rep., 4:515-519 (2002).
Clifford et al., “Treatment of canine hemangiosarcoma: 2000 and beyond”,J. Vet. Intern. Med., 14:479-485 (2000).
Del Papa et al., “Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis”,Arthritis & Rheumatism, 50:1296-1304 (2004).
Eghbali-Fatourechi et al., “Circulating osteoblast-lineage cells in humans”,N. Engl J. Med, 352:1959-1966 (2005).
Fedok et al., “Angiosarcoma: current review”,Am J. Otolaryngol., 20:223-231 (1999).
Fosmire et al., “Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium”,Laboratory Investigation, 84:562-572 (2004).
Hai et al., “Primary splenic angiosarcoma: case report and literature review”,J. Natl. Med. Assoc., 92:143-146 (2000).
Hur et al., “Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis”,Arterioscler Thromb Vasc Biol., 24:288-293 (2004).
Khan et al., “Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry”,Cytometry Part B(Clinical Cytometry), 64B:1-8 (2005).
Liu et al., “Changes in cell surface molecules associated with in vitro culture of prostatic stromal cells”,The Prostate, 45:303-312 (2000).
Martin-Padura et al., “Expression of VE (vascular endothelial)-cadherin and other endothelial-specific markers in haemangiomas”,Journal of Pathology, 175:51-57 (1995).
Oksanen A., “Hemangiosarcoma in dogs”,J. Comp. Pathol., 88:585-595 (1978).
PCT International Search Report and Written Opinion mailed Mar. 11, 2008 for PCT/US05/31753.
Poblet et al., “Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas”,Virchows Arch, 428:217-221 (1996).
Shaw et al., “Hemapoietic stem cells and endothelial cell precursors express Tie-2, CD31 and CD45”,Blood Cells, Molecules, & Diseases, 32:168-175 (2004).
Sorenmo et al., “Canine hemangiosarcoma treated with standard chemotherapy and minocycline”,J. Vet. Intern. Med., 14:395-398 (2000).
Sorenmo et al., “Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide”,J. Vet. Intern. Med., 7:370-376 (1993).
Weiss DJ., “Flow Cytometric evaluation of hemophagocytic disorders in canine bone marrow”,Veterinary Clinical Pathology, 31:36-41 (2002).
Helfand Stuart C.
Modiano Jaime F.
Goddard Laura B
Kilpatrick Townsend & Stockton LLP
The Regents of the University of Colorado, a body corporate
LandOfFree
Early detection of hemangiosarcoma and angiosarcoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Early detection of hemangiosarcoma and angiosarcoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Early detection of hemangiosarcoma and angiosarcoma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2755310